Firas Hamdan

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Venues

Journal for immunotherapy of cancer

Nature communications

Journal of immunology (Baltimore, Md. : 1950)

University of Helsinki (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Helsinki Sep 03 2019

Finland

PHD

Universiteit Utrecht

Netherlands

MSC

University of Kent

United Kingdom

MSC

Publications

Sara Feola, Firas Hamdan, Salvatore Russo, Jacopo Chiaro, Manlio Fusciello, Michaela Feodoroff, Gabriella Antignani, Federica D'Alessio, Riikka Mölsä, Virpi Stigzelius, Paolo Bottega, Sari Pesonen, Jeanette H W Leusen, Mikaela Grönholm, Vincenzo Cerullo
Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors. Journal for immunotherapy of cancer 12 (3) (2024)
Sara Feola, Firas Hamdan, Salvatore Russo, Jacopo Chiaro, Manlio Fusciello, Michaela Feodoroff, Gabriella Antignani, Federica D'Alessio, Riikka Mölsä, Virpi Stigzelius, Paolo Bottega, Sari Pesonen, Jeanette H W Leusen, Mikaela Grönholm, Vincenzo Cerullo
Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors. Journal for immunotherapy of cancer 12 (3) (2024)
Sara Feola, Firas Hamdan, Salvatore Russo, Jacopo Chiaro, Manlio Fusciello, Michaela Feodoroff, Gabriella Antignani, Federica D'Alessio, Riikka Mölsä, Virpi Stigzelius, Paolo Bottega, Sari Pesonen, Jeanette H W Leusen, Mikaela Grönholm, Vincenzo Cerullo
Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors. Journal for immunotherapy of cancer 12 (3) (2024)
Sara Feola, Firas Hamdan, Salvatore Russo, Jacopo Chiaro, Manlio Fusciello, Michaela Feodoroff, Gabriella Antignani, Federica D'Alessio, Riikka Mölsä, Virpi Stigzelius, Paolo Bottega, Sari Pesonen, Jeanette H W Leusen, Mikaela Grönholm, Vincenzo Cerullo
Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors. Journal for immunotherapy of cancer 12 (3) (2024)
Jacopo Chiaro, Gabriella Antignani, Sara Feola, Michaela Feodoroff, Beatriz Martins, Hanne Cojoc, Salvatore Russo, Manlio Fusciello, Firas Hamdan, Valentina Ferrari, Daniele Ciampi, Ilkka Ilonen, Jari Räsänen, Mikko I Mäyränpää, Jukka Partanen, Satu Koskela, Jarno Honkanen, Jussi Halonen, Lukasz Kuryk, Maria Rescigno, Mikaela Grönholm, Rui Mamede Branca, Janne Lehtiö, Vincenzo Cerullo
Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors. Nature communications 14 (1) (2023)
Firas Hamdan, Erkko O Ylösmäki, Jacopo Chiaro, Yvonne Giannoula, Maeve Long, Manlio Fusciello, Sara Feola, Beatriz Martins, Michaela Feodoroff, Gabriella Antignani, Salvatore Russo, Otto Kari, Moon Lee, Petrus Järvinen, Harry Nisen, Anna Kreutzman, Jeanette H W Leusen, Mohamed El Missiry, Thomas G McWilliams, Mikaela Grönholm, Vincenzo Cerullo
Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids. Journal for immunotherapy of cancer 9 (8) (2022)
Mitchell Evers, Elizabeth Kruse, Firas Hamdan, Robert Jan Lebbink, Jeanette H W Leusen
Comment on "Type I CD20 Antibodies Recruit the B Cell Receptor for Complement-Dependent Lysis of Malignant B Cells". Journal of immunology (Baltimore, Md. : 1950) 200 (8) (2019)
Manlio Fusciello, Flavia Fontana, Siri Tähtinen, Cristian Capasso, Sara Feola, Beatriz Martins, Jacopo Chiaro, Karita Peltonen, Leena Ylösmäki, Erkko Ylösmäki, Firas Hamdan, Otto K Kari, Joseph Ndika, Harri Alenius, Arto Urtti, Jouni T Hirvonen, Hélder Almeida Santos, Vincenzo Cerullo
Artificially cloaked viral nanovaccine for cancer immunotherapy. Nature communications 10 (1) (2019)

Firas Hamdan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Firas Hamdan